Virion Biotherapeutics

Biotechnology Research • Coventry, England, United Kingdom • 1-10 Employees

Company overview

Headquarters	Coventry, England, United Kingdom
Website	virionbiotx.com
SIC	283
Employees	1-10
Socials

Key Contact at Virion Biotherapeutics

Nigel Dimmock

Founder

About Virion Biotherapeutics

Virion Biotherapeutics’ purpose is to develop the first rapid-acting, broad-spectrum therapeutic to treat the full range of viral respiratory diseases irrespective of the viruses that cause them, from the most acute infections to the common cold. We have shown this to be possible with our lead agent VH244 in highly-translatable in vivo preclinical models. Virion’s transformative approach is enabled by a unique RNA-based technology platform, extensive drug discovery and development expertise, and a leadership team committed to changing the treatment paradigm. Our success will be to minimize infectious-disease-related suffering as well as alleviate an enormous economic burden worldwide.

Virion Biotherapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$21,400,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Virion Biotherapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Virion Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2017-11-12	4	$17,200,000
2018-02-01	9	$4,200,000

Funding Insights

$21,400,000

Total funding amount

$4,200,000

Most recent funding amount

Number of funding rounds